- Home
- OPRX vs CBLL Comparison
OPRX vs CBLL Comparison
Compare OPRX & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRX
- CBLL
- Stock Information
- Founded
- OPRX 2006
- CBLL 2014
- Country
- OPRX United States
- CBLL United States
- Employees
- OPRX N/A
- CBLL N/A
- Industry
- OPRX Business Services
- CBLL
- Sector
- OPRX Consumer Discretionary
- CBLL
- Exchange
- OPRX Nasdaq
- CBLL Nasdaq
- Market Cap
- OPRX 380.6M
- CBLL 433.7M
- IPO Year
- OPRX N/A
- CBLL 2024
- Fundamental
- Price
- OPRX $18.25
- CBLL $12.16
- Analyst Decision
- OPRX Buy
- CBLL Strong Buy
- Analyst Count
- OPRX 8
- CBLL 6
- Target Price
- OPRX $11.81
- CBLL $33.00
- AVG Volume (30 Days)
- OPRX 373.4K
- CBLL 258.1K
- Earning Date
- OPRX 11-12-2025
- CBLL 11-11-2025
- Dividend Yield
- OPRX N/A
- CBLL N/A
- EPS Growth
- OPRX N/A
- CBLL N/A
- EPS
- OPRX N/A
- CBLL N/A
- Revenue
- OPRX $104,748,000.00
- CBLL $77,419,000.00
- Revenue This Year
- OPRX $17.92
- CBLL $35.46
- Revenue Next Year
- OPRX $10.91
- CBLL $28.18
- P/E Ratio
- OPRX N/A
- CBLL N/A
- Revenue Growth
- OPRX 25.89
- CBLL 42.16
- 52 Week Low
- OPRX $3.78
- CBLL $10.01
- 52 Week High
- OPRX $20.70
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- OPRX 49.17
- CBLL 46.04
- Support Level
- OPRX $17.45
- CBLL $11.20
- Resistance Level
- OPRX $18.93
- CBLL $12.99
- Average True Range (ATR)
- OPRX 1.14
- CBLL 0.52
- MACD
- OPRX -0.24
- CBLL 0.10
- Stochastic Oscillator
- OPRX 21.08
- CBLL 36.02
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.